Study of Angiogenic Cell Therapy for Progressive Pulmonary Hypertension
Clinical trial NCT03001414 · TERMINATED
Trial details
- NCT number
- NCT03001414
- Sponsor
- Northern Therapeutics
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-28
- Primary completion
- 2023-05-04
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.